Thromb Haemost 1991; 66(05): 565-568
DOI: 10.1055/s-0038-1646460
Original Article
Schattauer GmbH Stuttgart

Effects of Poloxamer 188 on the Assembly, Structure and Dissolution of Fibrin Clots

Marcus E Carr Jr.
1  The Coagulation Special Studies Laboratory, Departments of Medicine and Pathology, Medical College of Virginia, USA
2  The McGuire V. A. Medical Center Richmond, Virginia, USA
,
P L Powers
2  The McGuire V. A. Medical Center Richmond, Virginia, USA
,
Marsha R Jones
3  The Burroughs Wellcome Co., Research Triangle Park, NC, USA
› Author Affiliations
Further Information

Publication History

Received 18 December 1990

Accepted 24 April 1991

Publication Date:
25 July 2018 (online)

Summary

Poloxamer 188, N.F. (RheothRx®), a nonionic block copolymer composed of 2 hydrophilic polyoxyethylene chains connected by a hydrophobic polyoxypropylene chain, normalizes the viscosity of whole blood high in soluble fibrin(ogen) complexes. Normalization may be via a poloxamer 188-induced decrease in fibrin(ogen)-red cell interaction. Our study examined the influences of poloxamer 188 on fibrin assembly and structure. Studies were performed in both purified and plasma systems with a poloxamer 188 concentration range of 0.1-20 mg/ml and specific clotting conditions (fibrinogen 1 mg/ml, thrombin 1 NIH u/ml, pH 7.4 [Tris 0.05 M], ionic strength 0.15 and calcium 5 mM). Fibrin assembly was accelerated in the presence of poloxamer 188. As poloxamer 188 concentration was increased from 0 to 8 mg/ml in plasma: a) the lag phase prior to initial turbidity rise decreased from 25 to <5 s; b) the final gel optical density (OD) increased from 0.65 to 1.28 and c) fiber size (mass/length ratio [ε]) increased from 4.3 to 12.6 × 1013 daltons/cm. Similar results were seen in the purified system with a poloxamer 188 concentration range of 0-8 mg/ml. OD increased from 0.26 to 0.51, and ε increased from 2.3 to 5.3 × 1013 daltons/cm. Above 8 mg/ml, precipitation of fibrinogen was noted in this system. Since large fibrin fibers tend to be degraded more rapidly, possible poloxamer mediated enhancement of r-tPA-mediated clot lysis was investigated. With r-tPA (70 lu/ml) present at the time of clotting, clot lysis in the presence of ploxamer 188 (8 mg/ml) was 50% complete at 1,600 s compared to 2,540 s for the control. Thus, poloxamer 188-induced alterations in fibrin structure and fibrin-cell interactions may explain some of this agent's interesting hemorrheologic and antithrombotic properties.